A Multi-Center, Open -label Pharmacokintic, Pharmocodynamic, Clinical Synptoms, and Safety Study of Pantoprazole Delayed-Released Granules Administered as A Suspension in Neonates and Preterm Infants with a Clinical Diagnosis of Gatroesophageal Disease.